Cargando…
Postrandomization Confounding Challenges the Applicability of Randomized Clinical Trials in Comparative Effectiveness Research
Autores principales: | Peng, Ya-Guang, Nie, Xiao-Lu, Feng, Jing-Jing, Peng, Xiao-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407048/ https://www.ncbi.nlm.nih.gov/pubmed/28397731 http://dx.doi.org/10.4103/0366-6999.204117 |
Ejemplares similares
-
Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials
por: Miller, David Gibbes, et al.
Publicado: (2018) -
Manganese as a Potential Confounder of Serum Prolactin
por: Aschner, Michael
Publicado: (2006) -
Potential Confounder: Bernard and de Burbure Respond
por: Bernard, Alfred, et al.
Publicado: (2006) -
Removal of ineligible outcome cases reduces confounding
por: Walker, Alexander M, et al.
Publicado: (2018) -
Is this the end for ranitidine? NDMA presence continues to confound
por: Wagner, Jennifer A., et al.
Publicado: (2021)